-
-
2.
公开(公告)号:EP3848382B1
公开(公告)日:2023-11-29
申请号:EP21160246.1
申请日:2017-05-18
-
3.
公开(公告)号:EP3927719B9
公开(公告)日:2023-08-23
申请号:EP20706678.8
申请日:2020-02-19
-
公开(公告)号:EP4190359A1
公开(公告)日:2023-06-07
申请号:EP21383098.7
申请日:2021-12-03
IPC分类号: A61K47/55 , A61K47/64 , A61K39/39 , A61K39/385 , A61K39/00 , C07H15/256 , C07J51/00 , A61P25/28 , A61P31/00 , A61P35/00
摘要: The present application relates to adjuvants and adjuvant-antigen conjugate vaccines based on a triterpene glycoside saponin scaffold incorporating an oxime group at position C4 of the triterpene domain and pharmaceutical compositions thereof as well as the use of said compounds and compositions in the treatment of and immunization for diseases such as neurodegenerative and infectious diseases and cancers.
-
-
公开(公告)号:EP4061376A2
公开(公告)日:2022-09-28
申请号:EP20891095.0
申请日:2020-11-24
发明人: PUROHIT, Parva Yogeshchandra , BRAHMKSHATRIYA, Pathik Subhashchandra , GOSWAMI, Vishalgiri Gunvantgiri
IPC分类号: A61K31/565 , C07J51/00 , A61P35/00
-
公开(公告)号:EP3392260B1
公开(公告)日:2022-09-21
申请号:EP18162373.7
申请日:2013-12-18
IPC分类号: C07J1/00 , C07J5/00 , C07J7/00 , C07J21/00 , C07J41/00 , A61K31/56 , A61K31/565 , A61K31/566 , A61K31/573 , A61K31/58 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , C07J51/00 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/32 , A61P29/00 , A61P43/00 , A61P9/10 , A61P11/06 , A61P23/00 , A61P23/02
-
公开(公告)号:EP3992201A1
公开(公告)日:2022-05-04
申请号:EP21195801.2
申请日:2013-06-17
发明人: STEINER, André , WAENERLUND POULSEN, Heidi , JOLIBOIS, Emilie , REWOLINSKI, Melissa , GROSS, Ralf , SHARP, Emma , DUBAS-FISHER, Fiona , EBERLIN, Alex
IPC分类号: C07J9/00 , C07J51/00 , A61P1/16 , A61P3/06 , A61P9/00 , A61P9/10 , A61P13/04 , A61P31/14 , A61P43/00 , A61K9/20 , A61K31/575
摘要: The present invention relates to obeticholic acid: or a pharmaceutically acceptable salt, solvate or amino acid conjugate thereof. Obeticholic acid is useful for the treatment or prevention of a FXR mediated disease or condition, cardiovascular disease or cholestatic liver disease, and for reducing HDL cholesterol, for lowering triglycerides in a mammal, or for inhibition of fibrosis. The present invention also relates to processes for the synthesis of obeticholic acid.
-
公开(公告)号:EP3978507A1
公开(公告)日:2022-04-06
申请号:EP21186868.2
申请日:2014-08-11
申请人: Emory University
发明人: GUTHRIE, David Brian , LOCKWOOD, Mark Andrew , NATCHUS, Michael G. , LIOTTA, Dennis C. , STEIN, Donald. G. , SAYEED, Iqbal
IPC分类号: C07J71/00 , C07J7/00 , A61K31/56 , A61P25/00 , A61K31/57 , A61K31/58 , A61K31/661 , A61K45/06 , C07J41/00 , C07J43/00 , C07J51/00
摘要: This disclosure relates to progesterone phophate derivatives and uses related thereto. In certain embodiments, the disclosure relates to compounds disclosed herein and uses for managing inflammation such as those resulting from traumatic brain injury or stroke.
-
公开(公告)号:EP3941926A1
公开(公告)日:2022-01-26
申请号:EP20708504.4
申请日:2020-03-11
申请人: Farmabios S.p.A.
IPC分类号: C07J51/00
-
-
-
-
-
-
-
-
-